OVERVIEW OF THE CLINICAL TRANSLATIONAL CORE AND IMPORTANCE OF THE CORE TO THE RESEARCH EFFORT We have identified the critical requirement to have a clinical translational core within the CCNE to coordinate application of our nanotechnologies to patient blood samples already collected and archived by other efforts. This core was not part of the original CCNE, but as we have started to apply our technologies to clinical specimens we feel it is an important core going forward in our renewal. For both blood protein biomarker and circulating tumor cell studies, the goal of this core is to utilize specimens already collected and prospectively being collected by other efforts (e.g., NCI ICMIC P50) in a systematic fashion with our nano-sensors being developed in RP2 and RP3. In addition, for the in vivo molecular imaging studies (endoscopic Raman imaging, photoacoustic molecular imaging) the goal of this core is to work with the NCI nanocharacterization labs and the Food and Drug Administration (FDA) in order to translate our nanoparticles into future clinical molecular imaging trials. Note, it is not the purpose of this core to actually collect samples from patients or to perform clinical trials, but just to facilitate clinical translation of nanotechnologies developed in the CCNE. Note also that the CCNE mechanism does not allow funding for prospective clinical trials, but by having this core we can bridge to other funded activities as well as apply for new funding for our clinical trials, to which we are whole-heartedly committed. In addition, the Canary Foundation is providing significant funding (in excess of $3IVI) for clinical trials for early cancer detection and providing partial funding for this and other cores (see Appendix 1 and letter of support).

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-GRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
United States
Zip Code
Park, Seung-Min; Lee, Jae Young; Hong, Soongweon et al. (2016) Dual transcript and protein quantification in a massive single cell array. Lab Chip 16:3682-8
Lee, Jung-Rok; Sato, Noriyuki; Bechstein, Daniel J B et al. (2016) Experimental and theoretical investigation of the precise transduction mechanism in giant magnetoresistive biosensors. Sci Rep 6:18692
SoRelle, Elliott D; Liba, Orly; Campbell, Jos L et al. (2016) A hyperspectral method to assay the microphysiological fates of nanomaterials in histological samples. Elife 5:
Sun, Ziyan; Cheng, Kai; Wu, Fengyu et al. (2016) Robust surface coating for a fast, facile fluorine-18 labeling of iron oxide nanoparticles for PET/MR dual-modality imaging. Nanoscale 8:19644-19653
Zhang, Ruiping; Cheng, Kai; Antaris, Alexander L et al. (2016) Hybrid anisotropic nanostructures for dual-modal cancer imaging and image-guided chemo-thermo therapies. Biomaterials 103:265-77
Koh, Ai Leen; Gidcumb, Emily; Zhou, Otto et al. (2016) Oxidation of Carbon Nanotubes in an Ionizing Environment. Nano Lett 16:856-63
Van de Sompel, Dominique; Sasportas, Laura S; Jokerst, Jesse V et al. (2016) Comparison of Deconvolution Filters for Photoacoustic Tomography. PLoS One 11:e0152597
Lee, Jung-Rok; Bechstein, Daniel J B; Ooi, Chin Chun et al. (2016) Magneto-nanosensor platform for probing low-affinity protein-protein interactions and identification of a low-affinity PD-L1/PD-L2 interaction. Nat Commun 7:12220
Lee, Jung-Rok; Haddon, D James; Wand, Hannah E et al. (2016) Multiplex giant magnetoresistive biosensor microarrays identify interferon-associated autoantibodies in systemic lupus erythematosus. Sci Rep 6:27623
Liba, Orly; SoRelle, Elliott D; Sen, Debasish et al. (2016) Contrast-enhanced optical coherence tomography with picomolar sensitivity for functional in vivo imaging. Sci Rep 6:23337

Showing the most recent 10 out of 117 publications